3 penny stocks I’d buy after recent heavy falls!

I think these penny stocks could make me a decent stack of cash in the coming years. Here’s why I think these low-cost UK shares are winners.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I think these three penny stocks could be too good to miss following recent price weakness. Heres why I’d buy them right now. 

Woodbois Limited

Soaring demand for sustainable products means Woodbois Limited (LSE: WBI) could have a very bright future. This penny stock produces dozens of species of African hardwood from its assets in Gabon and Mozambique. And the company is ramping up capacity for its veneer and sawn timber lines to make the most of this massive growth opportunity.

Woodbois stands to gain from rising levels of urbanisation in emerging markets as well as that aforementioned switch to timber from other less environmentally-friendly materials. With housebuilding shortages also needing to be addressed, and tree planting an essential tool in helping lawmakers hit their net zero emissions targets, analysts at asset managers Gresham House think global timber demand will soar 170% over the next 30 years.

It’s true that the fragile economic recovery poses a threat to Woodbois. Demand for its hardwood could suffer badly if broader construction activity sinks in its markets. But as a long-term investor this low-cost UK share still has a lot to offer.

European Metals Holdings

Lithium business European Metals Holdings (LSE: EMH) has steadily lost ground over the past six months despite a steady stream of data showing how electric vehicle (EV) sales continue to boom. I see this as an opportunity to pick up a terrific EV-geared stock at a cut price.

You see, European Metals is developing the Cinovec lithium project in Czechia. The asset is Europe’s biggest lithium resource (as well as one of the world’s biggest tin deposits). In fact, the business recently hike its ore reserve estimates there from 34.5m tonnes to an even-more impressive 54.5m tonnes.

What I also like about European Metals is that Cinovec is located near many of the continent’s largest vehicle manufacturers. It therefore already has a potentially significant customer base on its doorstep.

Development problems at Cinovec could cause the penny stock’s share price to sink further. But, on balance, I think the possible rewards of owning European Metals outweighs the risks.

Science in Sport

Nutritional product manufacturer Science in Sport (LSE: SIS) isn’t without dangers of its own. Rising commodity prices pose a significant threat to the company’s bottom line in the short term and potentially beyond.

But, in my opinion, this danger is more than offset by the huge revenues potential of its winning sports supplement brands PhD Nutrition and Science in Sport. These hugely-popular labels cover a wide range of products for the get-fit obsessed, such as protein shakes, energy gels and vitamin supplements. Latest financials showed sales of these goods soar 25% in 2021, above the company’s own heady expectations.

I think Science in Sport could continue to print impressive revenues growth too as the market expands at breakneck pace. Industry experts at Mordor Intelligence think the sports nutrition sector will grow at a whopping compound annual growth rate of 12.5% between now and 2027.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A pastel colored growing graph with rising rocket.
Investing Articles

How much passive income could I make for every £1,000 invested in Aviva shares?

Even a relatively small investment in Aviva shares could generate much greater passive income, particularly if the dividends are reinvested…

Read more »

Close-up of British bank notes
Investing Articles

I’m considering 100 shares in this FTSE 250 gem to aim for £300 a month in dividends

Mark Hartley outlines why a lesser-known banking stock from the FTSE 250's worth considering for an income portfolio in 2024.

Read more »

Investing Articles

History suggests these UK shares might soar if interest rates are cut in August

Some UK shares could rocket if interest rates fall from its 5.25% high next month. And there's one our writer…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

Here’s why H1 results could boost the AstraZeneca share price

The AstraZeneca share price has been a success story in the past five years. With H1 results due, can it…

Read more »

Investing Articles

£17,365 in savings? Here’s how I’d use it to target a £6,700-a-month passive income

Here's how a lump sum investment could pave the way for me to make a four-figure monthly passive income in…

Read more »

Investing Articles

Down more than 10% in 6 months, Fools are backing these 5 UK stocks to reverse that – and then some! – by 2025

Some of our UK free-site writers have put forward their candidates for turnaround stocks!

Read more »

Investing Articles

Down 23%! Should I buy more CrowdStrike shares for my Stocks and Shares ISA?

Sometimes bad news can be good news for long-term investors. But is that the case for CrowdStrike in relation to…

Read more »

Investing Articles

2 UK shares near 52-week lows I’m considering snapping up

These UK shares are loitering near, or at, 52-week lows. Are these prime opportunities for our writer to boost her…

Read more »